End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
82.02 CNY | -2.93% | -3.62% | -15.36% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The firm trades with high earnings multiples: 28.24 times its 2024 earnings per share.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.36% | 2.26B | - | ||
+2.11% | 102B | A- | ||
-11.98% | 58.85B | A- | ||
+72.38% | 47.79B | B | ||
+8.17% | 36.9B | B | ||
+0.64% | 31.19B | A- | ||
+4.41% | 18.85B | B- | ||
+13.88% | 17.05B | C+ | ||
+5.77% | 13.95B | B- | ||
-5.51% | 13.14B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688281 Stock
- Ratings Shaanxi Huaqin Technology Industry Co.,Ltd.